Newcomb Jessica
Principal Accounting Officer
Newcomb Jessica has filed 1 SEC Form 4 filing (3 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Sep 24, 2026.
On the most recent filing, Newcomb Jessica is listed as Principal Accounting Officer at Tango Therapeutics, Inc. Inside the rolling window, Newcomb Jessica reported no open-market purchases and 1 open-market sale totaling $199K in TNGX.
Companies traded
Other insiders at TNGX
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$199K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Newcomb Jessica made?
Newcomb Jessica has filed 1 SEC Form 4 filing (3 transaction rows) across 1 company since 2026.
Which companies does Newcomb Jessica trade?
Newcomb Jessica has filed SEC Form 4 disclosures for 1 company, including TNGX.
When was Newcomb Jessica's most recent SEC Form 4 filing?
Newcomb Jessica's most recent SEC Form 4 filing on Tracefour is dated Sep 24, 2026.
What is Newcomb Jessica's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Newcomb Jessica is listed as Principal Accounting Officer.
What is Newcomb Jessica's total buy and sell value in the current window?
Inside the rolling retention window, Newcomb Jessica bought $0 and sold $199K based on SEC Form 4 filings.
What was Newcomb Jessica's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 8,200 TNGX shares on 2026-09-22, worth $199K, per SEC Form 4 filings.